Therapeutic and Economic Value of Everolimus Plus Exemestane for the Treatment of Postmenopausal Women with Hormone Receptor-Positive, Her2/Neu Negative Advanced Breast Cancer
Abstract
Authors
J Félix J Almeida D Ferreira S Rabiais B Vandewalle